Molecular Mechanisms of Drug Resistance in Natural Leishmania Populations Vary with Genetic Background

Overview

Journal PLoS Negl Trop Dis

Specialties Infectious Diseases
Tropical Medicine

Date 2012 Mar 6

PMID 22389733

Citations 49

Authors

Saskia Decuypere

Manu Vanaerschot

Kirstyn Brunker

Hideo Imamura

Sylke Muller

Basudha Khanal

Suman Rijal

Jean-Claude Dujardin

Graham H Coombs

Affiliations

Soon will be listed here.

Abstract

The evolution of drug-resistance in pathogens is a major global health threat. Elucidating the molecular basis of pathogen drug-resistance has been the focus of many studies but rarely is it known whether a drug-resistance mechanism identified is universal for the studied pathogen; it has seldom been clarified whether drug-resistance mechanisms vary with the pathogen's genotype. Nevertheless this is of critical importance in gaining an understanding of the complexity of this global threat and in underpinning epidemiological surveillance of pathogen drug resistance in the field. This study aimed to assess the molecular and phenotypic heterogeneity that emerges in natural parasite populations under drug treatment pressure. We studied lines of the protozoan parasite Leishmania (L.) donovani with differential susceptibility to antimonial drugs; the lines being derived from clinical isolates belonging to two distinct genetic populations that circulate in the leishmaniasis endemic region of Nepal. Parasite pathways known to be affected by antimonial drugs were characterised on five experimental levels in the lines of the two populations. Characterisation of DNA sequence, gene expression, protein expression and thiol levels revealed a number of molecular features that mark antimonial-resistant parasites in only one of the two populations studied. A final series of in vitro stress phenotyping experiments confirmed this heterogeneity amongst drug-resistant parasites from the two populations. These data provide evidence that the molecular changes associated with antimonial-resistance in natural Leishmania populations depend on the genetic background of the Leishmania population, which has resulted in a divergent set of resistance markers in the Leishmania populations. This heterogeneity of parasite adaptations provides severe challenges for the control of drug resistance in the field and the design of molecular surveillance tools for widespread applicability.

Citing Articles

Identification of CβS and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling.

Zarrinkar F, Sharifi I, Oliaee R, Afgar A, Molaakbari E, Bamorovat M Parasite Epidemiol Control. 2025; 28:e00413.

PMID: 39959455 PMC: 11830360. DOI: 10.1016/j.parepi.2025.e00413.

Genetic coping mechanisms observed in Leishmania tropica, from the Middle East region, enhance the survival of the parasite after drug exposure.

Glans H, Matos G, Bradley M, Downing T, Andersson B PLoS One. 2024; 19(12):e0310821.

PMID: 39625894 PMC: 11614225. DOI: 10.1371/journal.pone.0310821.

Potential selection of antimony and methotrexate cross-resistance in Leishmania infantum circulating strains.

Bernardo L, Ibarra-Meneses A, Douanne N, Corbeil A, Solana J, Beaudry F PLoS Negl Trop Dis. 2024; 18(2):e0012015.

PMID: 38422164 PMC: 10931519. DOI: 10.1371/journal.pntd.0012015.

The paradigm of intracellular parasite survival and drug resistance in leishmanial parasite through genome plasticity and epigenetics: Perception and future perspective.

Kamran M, Bhattacharjee R, Das S, Mukherjee S, Ali N Front Cell Infect Microbiol. 2023; 13:1001973.

PMID: 36814446 PMC: 9939536. DOI: 10.3389/fcimb.2023.1001973.

Potent Inhibitory Activity of Natural Product Anaephene B and Analogues against In Vitro.

Zaman S, Jones M Molecules. 2023; 28(3).

PMID: 36770614 PMC: 9920133. DOI: 10.3390/molecules28030946.

References

Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S . Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother. 2006; 50(5):1788-97. PMC: 1472228. DOI: 10.1128/AAC.50.5.1788-1797.2006. View

Sundar S, More D, Singh M, Singh V, Sharma S, Makharia A . Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis. 2000; 31(4):1104-7. DOI: 10.1086/318121. View

Vanaerschot M, De Doncker S, Rijal S, Maes L, Dujardin J, Decuypere S . Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. PLoS One. 2011; 6(8):e23120. PMC: 3148249. DOI: 10.1371/journal.pone.0023120. View

Beerenwinkel N, Knupfer P, Tresch A . Learning monotonic genotype-phenotype maps. Stat Appl Genet Mol Biol. 2011; 10:Article 3. DOI: 10.2202/1544-6115.1603. View

Downing T, Stark O, Vanaerschot M, Imamura H, Sanders M, Decuypere S . Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex. Infect Genet Evol. 2011; 12(1):149-59. PMC: 3315668. DOI: 10.1016/j.meegid.2011.11.005. View

Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S . Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells. Int J Parasitol. 2011; 41(13-14):1311-21. DOI: 10.1016/j.ijpara.2011.07.013. View

Dube A, Singh N, Sundar S, Singh N . Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitol Res. 2005; 96(4):216-23. DOI: 10.1007/s00436-005-1339-1. View

VAN MEIRVENNE N, JANSSENS P, Magnus E, Lumsden W, HERBERT W . Antigenic variation in syringe passaged populations of Trypanosoma (Trypanozoon) brucei. II. Comparative studies on two antigenic-type collections. Ann Soc Belg Med Trop. 1975; 55(1):25-30. View

Adaui V, Castillo D, Zimic M, Gutierrez A, Decuypere S, Vanaerschot M . Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. PLoS Negl Trop Dis. 2011; 5(5):e1021. PMC: 3091834. DOI: 10.1371/journal.pntd.0001021. View

10.

Shim H, Fairlamb A . Levels of polyamines, glutathione and glutathione-spermidine conjugates during growth of the insect trypanosomatid Crithidia fasciculata. J Gen Microbiol. 1988; 134(3):807-17. DOI: 10.1099/00221287-134-3-807. View

11.

Mukherjee A, Padmanabhan P, Singh S, Roy G, Girard I, Chatterjee M . Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother. 2007; 59(2):204-11. DOI: 10.1093/jac/dkl494. View

12.

Singh N, Almeida R, Kothari H, Kumar P, Mandal G, Chatterjee M . Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray. Parasitology. 2007; 134(Pt 6):777-87. DOI: 10.1017/S0031182007002284. View

13.

Rijal S, Yardley V, Chappuis F, Decuypere S, Khanal B, Singh R . Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?. Microbes Infect. 2007; 9(4):529-35. DOI: 10.1016/j.micinf.2007.01.009. View

14.

Mikus J, Steverding D . A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitol Int. 2001; 48(3):265-9. DOI: 10.1016/s1383-5769(99)00020-3. View

15.

Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E . Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis. 1999; 180(2):564-7. DOI: 10.1086/314896. View

16.

Flohe L, Hecht H, Steinert P . Glutathione and trypanothione in parasitic hydroperoxide metabolism. Free Radic Biol Med. 1999; 27(9-10):966-84. DOI: 10.1016/s0891-5849(99)00172-0. View

17.

Carter K, Hutchison S, Boitelle A, Murray H, Sundar S, Mullen A . Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy. Parasitology. 2005; 131(Pt 6):747-57. DOI: 10.1017/S0031182005008486. View

18.

Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R . Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother. 2010; 65(3):496-507. DOI: 10.1093/jac/dkp468. View

19.

Inocencio da Luz R, Vermeersch M, Dujardin J, Cos P, Maes L . In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob Agents Chemother. 2009; 53(12):5197-203. PMC: 2786351. DOI: 10.1128/AAC.00866-09. View

20.

Ashutosh , Sundar S, Goyal N . Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol. 2007; 56(Pt 2):143-53. DOI: 10.1099/jmm.0.46841-0. View